{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:48:31Z","timestamp":1782269311437,"version":"3.54.5"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study was to explore the difference and significance of parietal pleura invasion and rib invasion in pathological T classification with non-small cell lung cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 8681 patients after lung resection were selected to perform analyses. Multivariable Cox analysis was used to identify the mortality differences in patients between parietal pleura invasion and rib invasion. Eligible patients with chest wall invasion were re-categorized according to the prognosis. Cancer-specific survival curves for different pathological T (pT) classifications were presented.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 466 patients considered parietal pleura invasion, and 237 patients served as rib invasion. Cases with rib invasion had poorer survival than those with the invasion of parietal pleura (adjusted hazard ratio [HR]= 1.627, <jats:italic>P<\/jats:italic> =0.004). In the cohort for parietal pleura invasion, patients with tumor size \u22645cm reached more satisfactory survival outcomes than patients with tumor size &amp;gt;5cm (unadjusted HR =1.598, <jats:italic>P<\/jats:italic> =0.006). However, there was no predictive difference in the cohort of rib invasion. The results of the multivariable analysis revealed that the mortality with parietal pleura invasion plus tumor size \u22645cm were similar to patients with classification pT3 (<jats:italic>P<\/jats:italic> =0.761), and patients for parietal pleura invasion plus tumor size &amp;gt;5cm and pT4 had no stratified survival outcome (P =0.809). Patients identified as rib invasion had a poorer prognosis than patients for pT4 (<jats:italic>P<\/jats:italic> =0.037).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Rib invasion has a poorer prognosis than pT4. Patients with parietal pleura invasion and tumor size with 5.1-7.0cm could be appropriately up-classified from pT3 to pT4.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.878482","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T08:26:41Z","timestamp":1651134401000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["The Difference and Significance of Parietal Pleura Invasion and Rib Invasion in Pathological T Classification With Non-Small Cell Lung Cancer"],"prefix":"10.3389","volume":"12","author":[{"given":"Lei-Lei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Wu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Quan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Kang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA: A Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21390","article-title":"Lung Cancer - Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual","volume":"67","author":"Rami-Porta","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The Eighth Edition Lung Cancer Stage Classification","volume":"151","author":"Detterbeck","year":"2017","journal-title":"Chest"},{"key":"B5","unstructured":"Non-Small Cell Lung Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.02.012","article-title":"The IASLC Lung Cancer Staging Project: A Renewed Call to Participation","volume":"13","author":"Giroux","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/JTO.0000000000000559","article-title":"The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer","volume":"10","author":"Rami-Porta","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.lungcan.2021.07.010","article-title":"Proposal for Rib Invasion as an Independent T Descriptor for Non-Small Cell Lung Cancer: A Propensity-Score Matching Analysis","volume":"159","author":"Zhao","year":"2021","journal-title":"Lung Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-019-01093-8","article-title":"Chest Wall\/Parietal Pleural Invasions Worsen Prognosis in T4 Non-Small Cell Lung Cancer Patients After Resection","volume":"67","author":"Yabuki","year":"2019","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(01)03264-7","article-title":"Characteristics and Prognosis of Resected T3 Non-Small Cell Lung Cancer","volume":"73","author":"Riquet","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2012.05.069","article-title":"Modern Surgical Results of Lung Cancer Involving Neighboring Structures: A Retrospective Analysis of 531 Pt3 Cases in a Japanese Lung Cancer Registry Study","volume":"144","author":"Kawaguchi","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.01.320","article-title":"PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB\u2013IIIB NSCLC: LCMC3 Trial Primary Analysis","volume":"16","author":"Lee","year":"2021","journal-title":"J Thorac Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.8.846","article-title":"Surgical Treatment of 125 Patients With Non-Small Cell Lung Cancer and Chest Wall Involvement","volume":"51","author":"Pitz","year":"1996","journal-title":"Thorax"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.5.1341","article-title":"Non-Small Cell Lung Cancer With Chest Wall Invasion: Evolution of Surgical Treatment and Prognosis in the Last 3 Decades","volume":"123","author":"Roviaro","year":"2003","journal-title":"Chest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(99)00456-7","article-title":"Extent of Chest Wall Invasion and Survival in Patients With Lung Cancer","volume":"68","author":"Downey","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2001.112826","article-title":"Chest Wall Invasion in Non-Small Cell Lung Carcinoma: A Rationale for En Bloc Resection","volume":"121","author":"Facciolo","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/ejcts\/ezaa027","article-title":"Prognostic Factors Following Complete Resection of Non-Superior Sulcus Lung Cancer Invading the Chest Wall","volume":"58","author":"Jones","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2004.07.038","article-title":"Resection of Chest Wall Invasion in Patients With Non-Small Cell Lung Cancer","volume":"26","author":"Matsuoka","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(00)00537-6","article-title":"Factors Affecting Long-Term Survival After En-Bloc Resection of Lung Cancer Invading the Chest Wall","volume":"18","author":"Chapelier","year":"2000","journal-title":"Eur J Cardiothorac Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12957-020-02090-5","article-title":"Association Between Number of Dissected Lymph Nodes and Survival in Stage IA Non-Small Cell Lung Cancer: A Propensity Score Matching Analysis","volume":"18","author":"Wu","year":"2020","journal-title":"World J Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.lungcan.2021.06.003","article-title":"The Modification of T Description According to Visceral Pleural Invasion and Tumor Size From 3.1cm to 4.0cm in Non-Small Cell Lung Cancer: A Retrospective Analysis Based on the SEER Database","volume":"158","author":"Qi","year":"2021","journal-title":"Lung Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.878482\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T08:26:49Z","timestamp":1651134409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.878482\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":21,"alternative-id":["10.3389\/fonc.2022.878482"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.878482","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"article-number":"878482"}}